Kardiyovasküler Hastalık Risk Faktörlerinde Azalma
Aterosiklerosis/Felç'de Azalma
Castillo-Richmond A., et al. Effects of the Transcendental Meditation Program on carotid atherosclerosis in hypertensive African Americans, Stroke 31: 568-573, 2000. Tam metin
Daha Düşük Tansiyon
Alexander C.N., et al. Transcendental Meditation, mindfulness, and longevity: An experimental study with the elderly. Journal of Personality and Social Psychology 57:950-964, 1989.
Alexander C.N., et al. Trial of stress reduction for hypertension in older African Americans (part II): sex and risk subgroup analysis. Hypertension 28:228-237, 1996.
Anderson J.W., et al. Blood pressure response to Transcendental Meditation: a meta-analysis. American Journal of Hypertension 21 (3): 310-6, 2008.
Barnes V.A., et al. Impact of Transcendental Meditation on ambulatory blood pressure in African-American adolescents. American Journal of Hypertension 17: 366-369, 2004.
Barnes V. A., et al. Stress, stress reduction, and hypertension in African Americans. Journal of the National Medical Association, 89, 464-476, 1997.
Barnes V. A., et al. (1999). Acute effects of Transcendental Meditation on hemodynamic functioning in middle-aged adults. Psychosomatic Medicine, 61, 88, 525-531.
Rainforth M.V., et al. Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis. Current Hypertension Reports 9:520–528, 2007. Tam Metin
Schneider R.H., et al. A randomized controlled trial of stress reduction in the treatment of hypertension in African Americans during one year. American Journal of Hypertension 18(1): 88-98, 2005. Tam Metin
Schneider R.H., et al. Long-term effects of stress reduction on mortality in persons > 55 years of age with systemic hypertension. American Journal of Cardiology 95:1060-1064, 2005. Tam Metin
Schneider R.H., et al. A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension 26: 820-827, 1995.
Kolesterol'de Azalma
Cooper M. J., et al. Transcendental Meditation in the management of hypercholesterolemia. Journal of Human Stress 5(4): 24–27, 1979.
Cooper M. J. and Aygen M. M. Effect of Transcendental Meditation on serum cholesterol and blood pressure. Harefuah, Journal of the Israel Medical Association 95(1): 1-2, 1978.
Konjestif Kalp Yetmezliğinde Azalma
Jayadevappa R., et al. Effectiveness of Transcendental Meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethnicity and Disease 17: 72-77, 2007. Tam Metin
Serbest Radikallerde Azalma
Schneider R.H., et al. Lower lipid peroxide levels and practitioners of the Transcendental Meditation program. Psychosomatic Medicine 60: 38-41, 1998.
Van Wijk E.P.A., et al. Anatomical characterization of human ultraweak photon emission in practitioners of Transcendental Meditation and control subjects. Journal of Alternative & Complementary Medicine 12:31-38, 1998.
Van Wijk E.P.A., et al. Differential Effects of Relaxation Techniques on Ultraweak Photon Emission. Journal of Alternative & Complementary Medicine 14:241-250, 2008.
Metabolik Sendrom'da Azalma/Pre-Diyabet
Paul-Labrador M., et al. Effects of randomized controlled trial of Transcendental Meditation on components of the metabolic syndrome in subjects with coronary heart disease. Archives of Internal Medicine 166:1218-1224, 2006. Tam Metin
Kardiovasküler Hastalıklar ve Risk Faktörleri Üzerine Yapılmış Yayınlarla İlgili Değerlendirmeler
Alexander C.N., et al. Effects of Transcendental Meditation compared to other methods of relaxation and meditation in reducing risk factors, morbidity and mortality. Homeostasis 35:243-264, 1994.
Barnes V.A., and Orme-Johnson D. W. Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults: A Research Review. Current Hypertension Reviews 2:207-218, 2006.
Schneider R.H., et al. Cardiovascular disease prevention and health promotion with the Transcendental Meditation program and Maharishi Consciousness-Based Health Care. Ethnicity and Disease 16 (3 Suppl 4):S4-15-26, 2006. Tam Metin
Walton K.G., et al. Review of controlled clinical research on the Transcendental Meditation program and cardiovascular disease: Risk factors, morbidity, and mortality. Cardiology in Review 12(5): 262-266, 2004. Tam Metin
Walton K.G., et al. Psychosocial stress and cardiovascular disease, Part 2: Effectiveness of the Transcendental Meditation program in treatment and prevention. Behavioral Medicine 28: 106-123, 2002.
